This inventor holds 1 USPTO granted patent and 1 EPO patent. Top assignee: Institute for Basic Science. Active years: 2022.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2022
Title: Dae Sik Kim: Innovator in Genome Editing Technologies
Introduction
Dae Sik Kim is a prominent inventor based in Incheon, South Korea. He has made significant contributions to the field of genome editing, particularly in the detection of off-target sites of programmable nucleases. His innovative work is crucial for enhancing the precision of genetic modifications.
Latest Patents
Dae Sik Kim holds a patent titled "Method for detecting off-target sites of programmable nucleases in a genome." This patent describes a method for identifying off-target sites through data analysis. The process involves subjecting the genome, isolated in vitro, to programmable nucleases that cleave the genome. Following this, whole genome sequencing or deep sequencing is performed. The Digenome-seq method disclosed in this patent can detect off-target sites on a genomic scale with high reproducibility. This innovation is essential for developing programmable nucleases with high target specificity.
Career Highlights
Dae Sik Kim is affiliated with the Institute for Basic Science, where he conducts his research. His work has garnered attention for its potential applications in genetic engineering and therapeutic interventions. He has demonstrated a commitment to advancing the field of genome editing through his research and patent contributions.
Collaborations
Dae Sik Kim collaborates with notable colleagues, including Jin Soo Kim and Sang Su Bae. These partnerships enhance the research environment and foster innovation in their shared field of study.
Conclusion
Dae Sik Kim's contributions to genome editing technologies, particularly through his patented methods, highlight his role as an influential inventor. His work not only advances scientific understanding but also paves the way for future innovations in genetic engineering.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
